A 12-page Executive Summary offering summary highlights for 22 Accountable Care Organizations and ACO solutions companies regarding their successes during the most recent MSSP performance year.
AHIP: 10 Most Common Treatments Subject to Prior Authorization
- Genetic Testing: 100%
- Specialty drugs: 100%
- Elective inpatient surgical services: 92%
- Elective inpatient medical services: 88%
- High cost non-specialty prescription drugs: 88%
- High-tech imaging: 88%
- Post acute care facility services: 88%
- Cardiology: 80%
- DME: 80%
- Orthopedics: 80%
Source: America's Health Insurance Plans (AHIP), November 14, 2022 - https://www.ahip.org/documents/2022-Prior-Auth-Survey-Results-FINAL.pdf
ACO Performance Case Studies
*By signing up for this offer you agree to receive the Accountable Care bulletin and the HealthExecWire news release bulletin.
Accountable Care
Offerings
Value-Based Payments
Offerings
Analytics
Offerings
Population Health
Offerings
Payers & Providers
Offerings